Skip to main content

Table 4 New mutations found in the present study

From: Glucocerebrosidase Mutations in Gaucher Disease

Patient #

cDNA Number

Genomic Number

Base Substitution

Exon

Amino Acid Number

Amino Acid Substitution

Rapid Detection Method

Other Mutation

Age at Dx/Current Age

Type

Severity Score (8)

Pvl.1.

1

203

1707

C→del

3

29

Pro→Arga

ASOHd

1226G

9/34

I

19

−/−

2

644

3438

C→A

6

176

Ala→Asp

−PflMI

?

11/31

I

7

+/+

2A

1226G

22/38

I

4

+/−

3

661

3455

C→A

6

182

Pro→Thr

−HphI

1226G

12/47

I

8

−/−

4

721

3515

G→Ab

6

202

Gly→Arg

−NciI

1226G

19/53

I

6

−/−

4A

1226G

29/38

I

6

+/−

4B

1448C

0.5/died at 3

II

24

+/−

5

887

4236

G→A

7

257

Arg→Gln

−BsmAI

1226G

51/8

I

14

−/−

6

970

4319

C→T

7

285

Arg→Cys

(+Nsi)c

1226G

39/20

I

10

−/−

7

1249

5864

T→G

9

378

Trp→Gly

ASOHd

764A

20/59

I

11

+/+

8

1255

5870

G→A

9

380

Asp→Asn

(+XcmI)c

1226G

71/40

I

8

+/−

  1. All patients were unrelated non-Jewish individuals with Gaucher disease. Patient designations without letter represent the index case.
  2. aFrame shift with early termination.
  3. bMutation creates the sequence found in the pseudogene.
  4. cRestriction site created artifically by mismatching a PCR primer.
  5. dAllele specific oligonucleotide hybridization.